
US FDA / EMA Approved Medicines
To Ensure Facilitation of procurement of all Specialty International Medicines unavailable in India at the best price for the patient.

Indian Manufacturer Medicines
A wide range of anti-cancer DGCI approved drugs could be found with top pharma manufacturing company in India

Medical Tourism / Second Opinion
The most popular treatments sought in India by medical tourists are alternative medicine, bone-marrow transplant, cardiac bypass, eye surgery, and hip replacement.

Medical Supplies & Equipment's
Our products are supplied all over India to government as well as private hospitals, nursing homes and medical colleges.
Indian Pharma Network (IPN)
Leading Pharma Distributor
In the New Delhi.
Getting medicine to patients in need through Patient Name Basis Treatment. Often grouped under the labels of compassionate use, expanded access, or named patient supply, these named patient program is governed by rules which vary by country defining access criteria.
We are associated with top Pharmaceutical Companies of the country. Building long lasting relationships in Pharma Distribution.
Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India :
New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur
Oncology Medications List
Anti cancer / Oncology Drug formulations and various other pharma formulations
Brentuximab Vedotin for injection
Hodgkin lymphoma, Systemic anaplastic large cell lymphoma. Approval 2011.
Gilteritinib tablets
Chronic lymphocytic leukemia (CML). Approval 2017.
Mitotane tablets
Cancer in the adrenal glands. Approval 1970.
Alectinib capsules
To treat non-small-cell lung cancer (NSCLC). Approval 2017.
Blinatumomab for injection
B-cell acute lymphoblastic leukemia (B-ALL). Approval 2014.
Bortezomib for Injection
Lymphoma, Multiple Myeloma Approval 2003.
Cobimetinib tablets
For the Treatment of Melanoma . Approval 2015.
Defibrotide sodium for injection
To treat veno-occlusive disease. Approval 2020.
Fam-trastuzumab deruxtecan-nxki for injection
Unresectable or metastatic HER2-positive breast cancer. Approval 2019
Cefiderocol for injection
To treat complicated urinary tract infections . Approval 2011.
Adalimumab Injection
To treat rheumatoid arthritis. Approval 2003.
Ponatinib tablets
Blast phase chronic myeloid leukemia (CML).
Leukemia. Approval 2012.
Trametinib tablet
Mutated metastatic melanoma. Approval 2013.
Nelarabine Injection
T-cell acute lymphoblastic. Approval 2005.
Ixazomib capsules
Multiple Myeloma. Approval: 2015
Polatuzumab vedotin-piiq for injection
Antibody-drug conjugate or ADC designed for the treatment of cancer. Approval 2019.
Dabrafenib capsules
BRAF V600E mutation-positive advanced melanoma. Approval 2013.
Sacituzumab govitecan-hziy for injection
Metastatic triple-negative breast cancer (mTNBC). Approval 2020.
Tucatinib tablets
HER2-positive breast cancer, brain
metastases. Approval: 2020
Venetoclax tablets
Chronic lymphocytic leukemia (CML). Approval 2017.
Daunorubicin and cytarabine liposome injection
Acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC). Approval 2017.
Team Members

Neeraj Nagpal
Business Development & Operations
22+ years of experience in pharma sales & marketing. Handles all operations over the country.

Himanshu Tiwari
Sales Coordinator, Mumbai
Serving the patients by dedicatedly working in the pharmaceuticals industry
Testimonials
Indian Pharma Network (IPN), New Delhi. India
Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa
Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
Free Customer Support
info@ipnintl.com
urgent@ipnintl.com